Read our latest publications
At NHMRC, we aim to create a workplace which supports all staff, regardless of their gender, age, cultural/religious background, sexual orientation or personal attributes. We want NHMRC to be a flexible and fair work environment, in which staff can flourish and where differences between employees are respected and viewed as an organisational asset.
Electronic cigarettes are often marketed as a method to assist smokers to quit, or as a ‘safe alternative’ to conventional tobacco cigarettes. There is currently insufficient evidence to support these claims. This statement explains the current evidence, to assist consumers and policy-makers.
The Ethical guidelines on the use of assisted reproductive technology in clinical practice and research (ART guidelines) are used by professional organisations to set standards for the practice of ART.
The 29th biannual report.
This plan identifies the workforce capability required by NHMRC to meet its objectives, now and into the future.
This document clarifies the responsibilities of those involved in clinical trials to monitor and report adverse events and other safety issues. Supplementary guidance on other clinical trial safety monitoring and reporting issues is also available.
There are times when NHMRC will issue information under embargo. This document details the reasons for this, allowable activities during embargo and how stakeholders may be notified the embargo will be lifted.
This policy clarifies the role and responsibilities of NHMRC Administering Institutions about notifying NHMRC of research integrity matters and describes how NHMRC responds to such matters.
This report was prepared in accordance with Public Governance, Performance and Accountability (non-corporate Commonwealth Entity) Annual Reporting Rule 2016. It contains information on NHMRC’s organisation, administration and performance for the reporting period 2015–16.
This document provides principles and best practice guidance for the care and use of non-human primates for scientific purposes. The document is intended for use by those involved in the care and use of non-human primates for scientific purposes, including institutional animal ethics committees, investigators and animal carers.
The active involvement of consumers and community members in health and medical research benefits the quality and direction of research. Consumer and community involvement is about research being carried out with or by consumers and community members rather than to, about or for them.
Human Research Ethics Committees (HRECs) registered with NHMRC are required to submit annual reports regarding their activities. This Report on the Activity outlines what is required in the reports as well as details about the HRECs registered in Australia.
The NHMRC Corporate Plan 2016–2017 covers the period 2016–17 to 2019–20. It includes NHMRC’s strategic directions, which prior to 2015–16 were set out in the strategic plan.
The 28th biannual report.
The International Engagement Strategy outlines our approach to prioritising new and existing activities with our international partners over the next three years.
The NHMRC Complaints Policy sets out NHMRC’s formal procedures for responding to complaints about its activities, policies or decision-making.
Ten of the Best NHMRC Research Projects 2015 describes ten Australian health and medical research projects chosen from among the thousands of NHMRC funded medical research projects underway in Australia today.
Showcasing ten research projects which illustrate the extraordinary quality and diversity of work being undertaken in 2016 with NHMRC support.
The Ethical guidelines for organ transplantation from deceased donors were developed by NHMRC following a joint request from the Organ and Tissue Authority and the Transplantation Society of Australia and New Zealand.
This book contains key statistics on the outcomes of the 2014 application rounds for NHMRC’s research funding, as well as historical information relating to research funding and activity over the last ten years.
The 27th biannual report.
A guide to the legislative and governance structure to refer to when accessing datasets from publicly funded research. This page also contains a single page summary to the guide and a consumer guide.
The October 2015 version of the January 2014 Funding Agreement and summary of changes. This version follows consultation with the research community.
The 26th biannual report.
This Corporate Plan sets out NHMRC’s purposes, planned activities and performance for the period 2015–16 to 2018–19, and addresses capability, environment and risk oversight and management in line with PGPA Act requirements.
The Guidelines approved under Section 95A of the Privacy Act 1988 are issued for the purposes of Australian Privacy Principles (APPs) and sections 16B(2) and 16B(3) of the Privacy Act.
These guidelines provide a framework in which medical research involving personal information obtained by Commonwealth agencies should be conducted, to ensure the information is protected.
This manual demonstrates the need for clinical ethics capacity in Australian health care organisations and provides guidance for institutions wishing to establish or strengthen an existing clinical ethics service.
The National principles of Intellectual Property management for publicly funded research provides guidance for the ownership, promotion, dissemination, exploitation and, where appropriate, protection of Intellectual Property generated through Australian Government funded research by public sector institutions.
Ten of the Best Research Projects 2014 describes ten Australian health and medical research projects chosen from among the thousands of NHMRC funded medical research projects underway in Australia today.
In 2011 NHMRC reviewed studies relating to the effectiveness of naltrexone implants for the treatment of opioid dependence, determining the implants remain an experimental product, only to be used in a research setting. NHMRC believes further research is required before a statement on safety can be confidently made.
This statement has been designed for researchers, ethical review bodies, those involved in research governance and possible research participants. This brief guide describes the structure of the document and suggests how each of these groups might use it.
This Statement and Information Paper were designed to inform the community and policy makers of the effects of lead on the human body. Evidence has shown an association with reduced academic achievement, behavioural problems, increased blood pressure and delayed sexual maturation.
This expert review is the summary of key issues from the report Evidence on the Effects of Lead on Human Health.
NHMRC’s Research Translation Faculty was established to suggest action that could be taken in the 2012-15 triennium to address significant evidence practice and policy gaps for Major Health Issues identified in its 2013-15 Strategic Plan. Twelve Cases for Action were submitted to NHMRC in 2015.
This Administrative report: Information Paper: Evidence on the effects of lead on human health refers to the development of the Information paper and Statement as well as background documents relating to the assessment of the evidence on the health effects of lead.
This document: Public consultation — summary of key issues: Draft information paper: Evidence on the effects of lead on human health outlines the key issues raised via public consultation and summaries of the Lead Working Committee’s responses.
NHMRC refuses to tolerate fraud and has a commitment to high ethical, moral and legal standards. A key focus of this framework is to raise awareness of fraud among NHMRC staff and other people who deal with NHMRC, to assist in the prevention, detection and reporting of suspected fraud.
This document provides a brief snapshot of the key messages from the NHMRC Corporate Plan 2015-2016.
The Principles for the translation of ‘omics’- based tests from discovery to health care are designed to assist researchers and clinicians in translating omics-based discoveries into properly validated tests that are clinically useful.
The NHMRC and ARC Statement on Open Researcher and Contributor ID explains NHMRC's position on the ORCID researcher identifier.
Institutions must meet set criteria in order to administer funding provided by the NHMRC. This document outlines the requirements needed in order to supervise the researchers and their projects which are receiving the Commonwealth Government funding, along with ensuring the value and integrity of the research.
NHMRC has been investigating concerns about the impact of wind farms on human health since 2009, following concerns raised by the public.
This administrative report refers to the development of a related information paper, NHMRC Statement and evidence-based background documents.
Following an earlier review of evidence linking wind farms to human health, NHMRC sought to update and review available information. The documents here focus on the methods used to conduct a systematic literature review focusing on noise, shadow flicker and electromagnetic radiation.
Some members of the community have raised concerns about the impact on their health while living near a wind farm.
This information paper summarises the available evidence on the subject along with key issues raised by the public and the expert community.
Examining whether wind farm emissions may affect human health is complex, due to the nature of the emissions and individual perceptions are highly variable. After careful consideration and deliberation of the body of evidence, NHMRC concludes there is currently no consistent evidence that wind farms cause adverse health effects in humans.
Many Australians report they use complementary medicine, but don't tell their clinicians which may impede treatment.
This resource aims to promote discussions between clinicians and patients about complementary medicine and better equip patients to make informed decisions about their health care.
NHMRC has reviewed the scientific evidence for the effectiveness of homeopathy in treating a variety of clinical conditions with the aim of providing Australians with reliable information about its use. This page contains the NHMRC Statement, the Information Paper detailing the evidence as well as an Administrative report.
This annual report is a record of NHMRC's activities during 2013–2014 financial year and the performance and financial information presented in the 2013–14 NHMRC Portfolio Budget Statement and 2013–14 NHMRC Portfolio Additional Estimates Statement.
This document is a five-year analysis of the scientific publication output and citation impact of research funded by NHMRC and of Australian health and medical research generally.
The aim of the report is to measure the impact of NHMRC funding schemes in terms of published journal output.